Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY Anticipated Dispensing Commencement and Flora Sync LF5 Commercial Launch Summer 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results